首页 > 最新文献

Anatolian Journal of Cardiology最新文献

英文 中文
Reply to Letter to the Editor: 'Cardiovascular Events After Coronavirus Disease 2019 Vaccinations: Hypersensitivity Myocarditis After Coronavirus Disease 2019 Vaccines, Diagnostic and Long-term Considerations'. 回复致编辑的信:"接种2019年冠状病毒病疫苗后的心血管事件:2019年冠状病毒病疫苗接种后的超敏性心肌炎、诊断和长期考虑"。
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-04-24 DOI: 10.14744/AnatolJCardiol.2024.4417
Hans-Bernd Bludau, Sergei V Jargin
{"title":"Reply to Letter to the Editor: 'Cardiovascular Events After Coronavirus Disease 2019 Vaccinations: Hypersensitivity Myocarditis After Coronavirus Disease 2019 Vaccines, Diagnostic and Long-term Considerations'.","authors":"Hans-Bernd Bludau, Sergei V Jargin","doi":"10.14744/AnatolJCardiol.2024.4417","DOIUrl":"10.14744/AnatolJCardiol.2024.4417","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168713/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Local Forearm Heating on Pain Intensity and Hemorrhage in Patients Undergoing Radial Artery Cardiac Catheterization: A Pilot Study. 局部前臂加热对桡动脉心导管手术患者疼痛强度和出血的影响:一项试点研究
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-04-17 DOI: 10.14744/AnatolJCardiol.2024.4112
Atefeh Shamsian, Ali Zahed Mehr, P. Tayebi, M. Fathollahi, Kamyar Amin, F. Shabani, Yasaman Daryabari
BACKGROUNDRadial artery cardiac catheterization is a common diagnostic and interventional procedure for cardiovascular conditions. Pain and hemorrhage at the access site can cause patient discomfort and complications. This pilot study investigates the potential of local forearm heating to reduce pain and hemorrhage in patients undergoing radial artery cardiac catheterization.METHODSWe enrolled 100 patients scheduled for radial artery cardiac catheterization and randomly assigned them to the heating or control group. The heating group received local forearm heating before sheath removal, while the control group did not. Pain intensity was assessed with a visual analog scale, and hemorrhage was measured by assessing ecchymosis or hematoma size at the catheterization site. Hemodynamic parameters were also monitored. Statistical analysis compared outcomes between the groups.RESULTSPatients who received local forearm heating had significantly lower pain intensity (4.15 ± 2.73) compared to the control group (5.84 ± 3.34) (P =.009). Hemodynamic parameters and the extent of hemorrhage at the catheterization site did not significantly differ between the heating and control groups (P >.05). No adverse effects related to forearm heating were reported.CONCLUSIONLocal forearm heating is a promising intervention to reduce pain intensity without increasing hemorrhage or affecting hemodynamic parameters during radial artery cardiac catheterization. This simple, noninvasive approach has the potential to enhance patient comfort and safety post procedure.
背景桡动脉心导管检查是一种常见的心血管疾病诊断和介入手术。入路部位的疼痛和出血会导致患者不适和并发症。这项试验性研究探讨了局部前臂加热对减轻桡动脉心导管检查患者疼痛和出血的潜在作用。加热组在拔出鞘管前对前臂进行局部加热,而对照组不进行加热。疼痛强度通过视觉模拟量表进行评估,出血量通过评估导管插入部位的瘀斑或血肿大小进行测量。此外,还对血液动力学参数进行了监测。结果与对照组(5.84 ± 3.34)相比,接受前臂局部加热的患者的疼痛强度(4.15 ± 2.73)明显降低(P =.009)。加热组和对照组的血流动力学参数和导管插入部位的出血程度没有明显差异(P >.05)。结论局部前臂加热是一种很有前景的干预方法,可在桡动脉心导管插入术中减轻疼痛强度,同时不会增加出血或影响血液动力学参数。这种简单、无创的方法有可能提高患者术后的舒适度和安全性。
{"title":"Impact of Local Forearm Heating on Pain Intensity and Hemorrhage in Patients Undergoing Radial Artery Cardiac Catheterization: A Pilot Study.","authors":"Atefeh Shamsian, Ali Zahed Mehr, P. Tayebi, M. Fathollahi, Kamyar Amin, F. Shabani, Yasaman Daryabari","doi":"10.14744/AnatolJCardiol.2024.4112","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2024.4112","url":null,"abstract":"BACKGROUND\u0000Radial artery cardiac catheterization is a common diagnostic and interventional procedure for cardiovascular conditions. Pain and hemorrhage at the access site can cause patient discomfort and complications. This pilot study investigates the potential of local forearm heating to reduce pain and hemorrhage in patients undergoing radial artery cardiac catheterization.\u0000\u0000\u0000METHODS\u0000We enrolled 100 patients scheduled for radial artery cardiac catheterization and randomly assigned them to the heating or control group. The heating group received local forearm heating before sheath removal, while the control group did not. Pain intensity was assessed with a visual analog scale, and hemorrhage was measured by assessing ecchymosis or hematoma size at the catheterization site. Hemodynamic parameters were also monitored. Statistical analysis compared outcomes between the groups.\u0000\u0000\u0000RESULTS\u0000Patients who received local forearm heating had significantly lower pain intensity (4.15 ± 2.73) compared to the control group (5.84 ± 3.34) (P =.009). Hemodynamic parameters and the extent of hemorrhage at the catheterization site did not significantly differ between the heating and control groups (P >.05). No adverse effects related to forearm heating were reported.\u0000\u0000\u0000CONCLUSION\u0000Local forearm heating is a promising intervention to reduce pain intensity without increasing hemorrhage or affecting hemodynamic parameters during radial artery cardiac catheterization. This simple, noninvasive approach has the potential to enhance patient comfort and safety post procedure.","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140693365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prognostic Accuracy of Get With The Guidelines-Heart Failure Score Alone and with Lactate Among Acute Symptomatic Heart Failure Patients: A Retrospective Cohort Study. 急性症状性心力衰竭患者中单独使用《指南》心力衰竭评分和乳酸评分的预后准确性:一项回顾性队列研究
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-04-17 DOI: 10.14744/AnatolJCardiol.2024.4116
Buğra İlhan, Göksu Bozdereli Berikol, H. Doğan, Attila Beştemir, Adnan Kaya
BACKGROUNDTo evaluate the prognostic accuracy of the Get With The Guidelines-Heart Failure (GWTG-HF) score, Shock Index (SI), Modified Shock Index (MSI), and Age Shock Index (Age-SI) alone and with lactate in patients with acute symptomatic heart failure (HF).METHODSA retrospective cohort study was conducted in the emergency department of a tertiary hospital between January 1, 2019, and December 31, 2019. Patients aged >18 years and diagnosed with acute symptomatic HF were consecutively included in the study. Patients referred from another center and missing medical records were excluded. Arrival type, vital parameters, demographic characteristics, comorbid diseases, consciousness status, laboratory results, and outcomes of the patients were recorded. The primary endpoint of the study was in-hospital mortality.RESULTSA total of 368 patients were included in the final analysis. The in-hospital mortality rate of the patients was 7.6%. The GWTG-HF score outperformed other scores in predicting in-hospital, 24-hour, and 30-day mortality (area under the curve (AUC) = 0.807, 0.844, and 0.765, P <.001, respectively). The overall performance of the GWTG-HF score with lactate (GWTG-HF+L) was better in predicting in-hospital, 24-hour, and 30-day mortality than the original GWTG-HF score (AUC = 0.872, 0.936, and 0.801, P <.001, respectively). Adding lactate values to the SI, MSI, and Age-SI improved their overall performance for all 3 outcomes.CONCLUSIONBoth the GWTG-HF and GWTG-HF+L scores have acceptable discriminatory power in patients with acute symptomatic HF. The GWTG-HF score, SI, MSI, and Age-SI can be used together with lactate to predict mortality in patients with acute HF.
背景评估Get With The Guidelines-心力衰竭(GWTG-HF)评分、休克指数(SI)、改良休克指数(MSI)和年龄休克指数(Age-SI)单独或与乳酸一起用于急性症状性心力衰竭(HF)患者的预后准确性。方法于2019年1月1日至2019年12月31日期间在一家三级医院的急诊科进行了一项回顾性队列研究。研究连续纳入了年龄大于 18 岁、确诊为急性症状性高血压的患者。从其他中心转诊和病历缺失的患者除外。研究记录了患者的到达类型、生命参数、人口统计学特征、合并疾病、意识状态、实验室结果和预后。研究的主要终点是院内死亡率。患者的院内死亡率为 7.6%。GWTG-HF 评分在预测院内、24 小时和 30 天死亡率方面优于其他评分(曲线下面积 (AUC) 分别为 0.807、0.844 和 0.765,P <.001)。在预测院内、24 小时和 30 天死亡率方面,加乳酸的 GWTG-HF 评分(GWTG-HF+L)的总体表现优于原始 GWTG-HF 评分(AUC = 0.872、0.936 和 0.801,P <.001)。结论GWTG-HF 和 GWTG-HF+L 评分对急性症状性心房颤动患者具有可接受的鉴别力。GWTG-HF 评分、SI、MSI 和 Age-SI 可与乳酸一起用于预测急性 HF 患者的死亡率。
{"title":"The Prognostic Accuracy of Get With The Guidelines-Heart Failure Score Alone and with Lactate Among Acute Symptomatic Heart Failure Patients: A Retrospective Cohort Study.","authors":"Buğra İlhan, Göksu Bozdereli Berikol, H. Doğan, Attila Beştemir, Adnan Kaya","doi":"10.14744/AnatolJCardiol.2024.4116","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2024.4116","url":null,"abstract":"BACKGROUND\u0000To evaluate the prognostic accuracy of the Get With The Guidelines-Heart Failure (GWTG-HF) score, Shock Index (SI), Modified Shock Index (MSI), and Age Shock Index (Age-SI) alone and with lactate in patients with acute symptomatic heart failure (HF).\u0000\u0000\u0000METHODS\u0000A retrospective cohort study was conducted in the emergency department of a tertiary hospital between January 1, 2019, and December 31, 2019. Patients aged >18 years and diagnosed with acute symptomatic HF were consecutively included in the study. Patients referred from another center and missing medical records were excluded. Arrival type, vital parameters, demographic characteristics, comorbid diseases, consciousness status, laboratory results, and outcomes of the patients were recorded. The primary endpoint of the study was in-hospital mortality.\u0000\u0000\u0000RESULTS\u0000A total of 368 patients were included in the final analysis. The in-hospital mortality rate of the patients was 7.6%. The GWTG-HF score outperformed other scores in predicting in-hospital, 24-hour, and 30-day mortality (area under the curve (AUC) = 0.807, 0.844, and 0.765, P <.001, respectively). The overall performance of the GWTG-HF score with lactate (GWTG-HF+L) was better in predicting in-hospital, 24-hour, and 30-day mortality than the original GWTG-HF score (AUC = 0.872, 0.936, and 0.801, P <.001, respectively). Adding lactate values to the SI, MSI, and Age-SI improved their overall performance for all 3 outcomes.\u0000\u0000\u0000CONCLUSION\u0000Both the GWTG-HF and GWTG-HF+L scores have acceptable discriminatory power in patients with acute symptomatic HF. The GWTG-HF score, SI, MSI, and Age-SI can be used together with lactate to predict mortality in patients with acute HF.","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140690625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reevaluating the Case of an Allegedly Absent Circumflex Artery: A Detailed Analysis of İnce et al.'s Report. 重新评估据称缺失的环状动脉病例:详细分析İnce等人的报告。
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-04-15 DOI: 10.14744/AnatolJCardiol.2024.4327
Zhanwen Xu, Yu Zhang
{"title":"Reevaluating the Case of an Allegedly Absent Circumflex Artery: A Detailed Analysis of İnce et al.'s Report.","authors":"Zhanwen Xu, Yu Zhang","doi":"10.14744/AnatolJCardiol.2024.4327","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2024.4327","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140701907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Letter to the Editor: 'Reevaluating the Case of an Allegedly Absent Circumflex Artery: A Detailed Analysis of İnce et al.'s Report'. 回复致编辑的信:"重新评估据称缺失的环状动脉病例:对İnce等人报告的详细分析"。
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-04-15 DOI: 10.14744/AnatolJCardiol.2024.4313
Orhan İnce, Kamil Gülşen, Sevil Tuğrul, İrfan Şahin, Ertuğrul Okuyan
{"title":"Reply to Letter to the Editor: 'Reevaluating the Case of an Allegedly Absent Circumflex Artery: A Detailed Analysis of İnce et al.'s Report'.","authors":"Orhan İnce, Kamil Gülşen, Sevil Tuğrul, İrfan Şahin, Ertuğrul Okuyan","doi":"10.14744/AnatolJCardiol.2024.4313","DOIUrl":"https://doi.org/10.14744/AnatolJCardiol.2024.4313","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059229/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telemedicine Interventional Therapy, Extra-cavity LV Image Registration…. 远程医疗介入治疗,腔外左心室图像注册....
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-04-01 DOI: 10.14744/AnatolJCardiol.2024.4
Çetin Erol
{"title":"Telemedicine Interventional Therapy, Extra-cavity LV Image Registration….","authors":"Çetin Erol","doi":"10.14744/AnatolJCardiol.2024.4","DOIUrl":"10.14744/AnatolJCardiol.2024.4","url":null,"abstract":"","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11017682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140317677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is it Time to Reappraise for Black-Box Warning on AngioJet Rheolytic Thrombectomy in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis. 是时候重新评估对肺栓塞患者实施 AngioJet 溶栓术的黑框警告了:系统回顾与元分析》。
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-03-26 DOI: 10.14744/AnatolJCardiol.2024.4081
Cihangir Kaymaz, Barkın Kültürsay, Hacer Ceren Tokgöz, Aykun Hakgör, Berhan Keskin, Özgür Yaşar Akbal, Ayhan Tosun, Seda Tanyeri, Ahmet Sekban, Çağdaş Buluş, Şeyhmus Külahçıoğlu, Ali Karagöz, İbrahim Halil Tanboğa, Nihal Özdemir

Background: AngioJet rheolytic thrombectomy (ART) system has been widely used as a catheter-directed treatment (CDT) method in acute pulmonary embolism (PE), however, there has been a controversy regarding the safety of its use. In this systematic review and meta-analysis, we evaluated the efficacy and safety outcomes of ART in patients with PE.

Methods: Our meta-analysis have been based on search in the MEDLINE, EMBASE, and Cochrane Library for studies published up to August 2022. The primary outcomes were overall pooled rates of major bleeding (MB) and minor bleeding (mB), worsening renal function (WRF), bradycardia/conduction disturbance (BCD), and PE-related and all-cause mortality in patients who underwent ART.

Results: Among the 233 studies documented at initial search, 24 studies were eligible for meta-analysis, and a total of 427 PE patients who underwent ART were evaluated. Overall pooled rates of MB and mB were 9.6% (95% CI 5.9%-15.2%) and 9.2% (95% CI 6.1%-13.6%), transient BCD and WRF were 18.2% (95% CI 12.4%-26%) and 15% (95% CI 10%-21.8%), and PE-related death and all-cause death were 12.7% (95% CI 9.1%-17.3%) and 15% (95% CI 11%-20%), respectively. However, significant heterogeneity and some evidence of funnel plot asymmetry and publication bias were noted for MB, BCD and WRF, but not for PE-related death and all-cause death.

Conclusion: Overall pooled rates of bleeding events, BCD and WRF episodes, PE-related death and all-cause death may be considered as encouraging results for efficacy and safety issues of ART utilization in specific scenarios of acute PE, and a reappraisal for black-box warning on ART seems to be necessary.

背景:AngioJet流变溶栓切除术(ART)系统作为一种导管导向治疗(CDT)方法已被广泛应用于急性肺栓塞(PE),但其使用的安全性一直存在争议。在这篇系统综述和荟萃分析中,我们评估了 ART 在 PE 患者中的疗效和安全性:我们的荟萃分析基于 MEDLINE、EMBASE 和 Cochrane 图书馆中截至 2022 年 8 月发表的研究。主要结果是接受抗逆转录病毒疗法患者的大出血(MB)和轻微出血(mB)、肾功能恶化(WRF)、心动过缓/传导障碍(BCD)以及 PE 相关死亡率和全因死亡率的总体汇总率:在最初搜索到的 233 项研究中,有 24 项研究符合荟萃分析条件,共对 427 名接受抗逆转录病毒疗法的 PE 患者进行了评估。MB和mB的总体汇总率分别为9.6%(95% CI 5.9%-15.2%)和9.2%(95% CI 6.1%-13.6%),一过性BCD和WRF分别为18.2%(95% CI 12.4%-26%)和15%(95% CI 10%-21.8%),PE相关死亡和全因死亡分别为12.7%(95% CI 9.1%-17.3%)和15%(95% CI 11%-20%)。然而,在MB、BCD和WRF方面,发现了明显的异质性以及漏斗图不对称和发表偏倚的一些证据,但在PE相关死亡和全因死亡方面没有发现异质性和发表偏倚:出血事件、BCD和WRF发作、PE相关死亡和全因死亡的总体汇总率可视为急性PE特定情况下使用抗逆转录病毒疗法的疗效和安全性问题的令人鼓舞的结果,似乎有必要重新评估抗逆转录病毒疗法的黑盒警告。
{"title":"Is it Time to Reappraise for Black-Box Warning on AngioJet Rheolytic Thrombectomy in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis.","authors":"Cihangir Kaymaz, Barkın Kültürsay, Hacer Ceren Tokgöz, Aykun Hakgör, Berhan Keskin, Özgür Yaşar Akbal, Ayhan Tosun, Seda Tanyeri, Ahmet Sekban, Çağdaş Buluş, Şeyhmus Külahçıoğlu, Ali Karagöz, İbrahim Halil Tanboğa, Nihal Özdemir","doi":"10.14744/AnatolJCardiol.2024.4081","DOIUrl":"10.14744/AnatolJCardiol.2024.4081","url":null,"abstract":"<p><strong>Background: </strong>AngioJet rheolytic thrombectomy (ART) system has been widely used as a catheter-directed treatment (CDT) method in acute pulmonary embolism (PE), however, there has been a controversy regarding the safety of its use. In this systematic review and meta-analysis, we evaluated the efficacy and safety outcomes of ART in patients with PE.</p><p><strong>Methods: </strong>Our meta-analysis have been based on search in the MEDLINE, EMBASE, and Cochrane Library for studies published up to August 2022. The primary outcomes were overall pooled rates of major bleeding (MB) and minor bleeding (mB), worsening renal function (WRF), bradycardia/conduction disturbance (BCD), and PE-related and all-cause mortality in patients who underwent ART.</p><p><strong>Results: </strong>Among the 233 studies documented at initial search, 24 studies were eligible for meta-analysis, and a total of 427 PE patients who underwent ART were evaluated. Overall pooled rates of MB and mB were 9.6% (95% CI 5.9%-15.2%) and 9.2% (95% CI 6.1%-13.6%), transient BCD and WRF were 18.2% (95% CI 12.4%-26%) and 15% (95% CI 10%-21.8%), and PE-related death and all-cause death were 12.7% (95% CI 9.1%-17.3%) and 15% (95% CI 11%-20%), respectively. However, significant heterogeneity and some evidence of funnel plot asymmetry and publication bias were noted for MB, BCD and WRF, but not for PE-related death and all-cause death.</p><p><strong>Conclusion: </strong>Overall pooled rates of bleeding events, BCD and WRF episodes, PE-related death and all-cause death may be considered as encouraging results for efficacy and safety issues of ART utilization in specific scenarios of acute PE, and a reappraisal for black-box warning on ART seems to be necessary.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168710/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140288000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fragmentation of the QRS Complex Is Associated with Right Ventricular Dilatation and Mortality in Critically Unwell Coronavirus Disease 2019 Patients. QRS 波群分裂与 2019 年冠状病毒病重症患者右心室扩张和死亡率有关。
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-03-26 DOI: 10.14744/AnatolJCardiol.2024.3494
Randeep S Heer, Faye L Selby, Amit K J Mandal, Vadir Baktash, Piotr Szawarski, Sirtaaj Mattoo, Hasan Mohiaddin, Kanchani K Makuloluwa, Hussein Chreif, Fouad R Amin, Constantinos G Missouris

Background: QRS fragmentation (fQRS) is a depolarization disorder that can be detected on routine electrocardiography (ECG). Current evidence suggests that fQRS is a prognosticator of adverse cardiovascular events. This study aimed to assess the relationship between fQRS and all-cause mortality in critically unwell coronavirus disease 2019 (COVID-19) patients and to investigate the significance of associated abnormalities on echocardiography.

Methods: A retrospective cohort study of COVID-19 patients in a critical care setting was performed. Electrocardiography was performed on presentation to hospital, admission to the critical care unit, and at subsequent points according to clinical need. Transthoracic echocardiography was performed at clinical discretion to assess for structural and functional cardiac abnormalities. Primary outcome was in-hospital mortality and secondary outcome was the need for mechanical invasive ventilation.

Results: Totally, 212 consecutive patients were included of which 120 (57%) exhibited fQRS and inferior leads were involved in 88% of the patients. Overall, fQRS was a significant predictor of mortality [65% vs. 44% P =.003; multivariate odds ratio = 2.96, 95% confidence interval (CI): 1.42-6.40, P =.005] and inferior fQRS itself was a significant predictor of mortality (P =.03). There was no significant association between fQRS and the need for invasive mechanical ventilation. A total of 112 patients underwent echocardiography. There was a greater incidence of right ventricular (RV) dilatation in the fQRS group (16% vs. 2% respectively, P =.02) and pulmonary hypertension (33% vs. 14% respectively, P =.03) based on echocardiographic criteria.

Conclusion: Our study demonstrates that fQRS is significantly associated with RV dilation, pulmonary hypertension, and mortality in critically unwell COVID-19 patients.

背景:QRS 分段(fQRS)是一种去极化障碍,可在常规心电图(ECG)上检测到。目前的证据表明,fQRS 是不良心血管事件的预后指标。本研究旨在评估2019年冠状病毒病(COVID-19)重症患者中fQRS与全因死亡率之间的关系,并探讨超声心动图相关异常的意义:对重症监护环境中的COVID-19患者进行了一项回顾性队列研究。在患者入院、进入重症监护室以及随后根据临床需要进行心电图检查。经胸超声心动图由临床决定是否进行,以评估心脏结构和功能异常。主要结果为院内死亡率,次要结果为是否需要进行有创机械通气:共纳入 212 例连续患者,其中 120 例(57%)表现为 fQRS,88% 的患者下导联受累。总体而言,fQRS 是死亡率的重要预测因素[65% vs. 44% P =.003;多变量比值比 = 2.96,95% 置信区间 (CI):1.42-6.40,P =.005],下导联本身也是死亡率的重要预测因素(P =.03)。fQRS与有创机械通气需求之间无明显关联。共有 112 名患者接受了超声心动图检查。根据超声心动图标准,fQRS 组右心室(RV)扩张(分别为 16% 和 2%,P =.02)和肺动脉高压(分别为 33% 和 14%,P =.03)的发生率更高:我们的研究表明,在 COVID-19 重症患者中,fQRS 与 RV 扩张、肺动脉高压和死亡率密切相关。
{"title":"Fragmentation of the QRS Complex Is Associated with Right Ventricular Dilatation and Mortality in Critically Unwell Coronavirus Disease 2019 Patients.","authors":"Randeep S Heer, Faye L Selby, Amit K J Mandal, Vadir Baktash, Piotr Szawarski, Sirtaaj Mattoo, Hasan Mohiaddin, Kanchani K Makuloluwa, Hussein Chreif, Fouad R Amin, Constantinos G Missouris","doi":"10.14744/AnatolJCardiol.2024.3494","DOIUrl":"10.14744/AnatolJCardiol.2024.3494","url":null,"abstract":"<p><strong>Background: </strong>QRS fragmentation (fQRS) is a depolarization disorder that can be detected on routine electrocardiography (ECG). Current evidence suggests that fQRS is a prognosticator of adverse cardiovascular events. This study aimed to assess the relationship between fQRS and all-cause mortality in critically unwell coronavirus disease 2019 (COVID-19) patients and to investigate the significance of associated abnormalities on echocardiography.</p><p><strong>Methods: </strong>A retrospective cohort study of COVID-19 patients in a critical care setting was performed. Electrocardiography was performed on presentation to hospital, admission to the critical care unit, and at subsequent points according to clinical need. Transthoracic echocardiography was performed at clinical discretion to assess for structural and functional cardiac abnormalities. Primary outcome was in-hospital mortality and secondary outcome was the need for mechanical invasive ventilation.</p><p><strong>Results: </strong>Totally, 212 consecutive patients were included of which 120 (57%) exhibited fQRS and inferior leads were involved in 88% of the patients. Overall, fQRS was a significant predictor of mortality [65% vs. 44% P =.003; multivariate odds ratio = 2.96, 95% confidence interval (CI): 1.42-6.40, P =.005] and inferior fQRS itself was a significant predictor of mortality (P =.03). There was no significant association between fQRS and the need for invasive mechanical ventilation. A total of 112 patients underwent echocardiography. There was a greater incidence of right ventricular (RV) dilatation in the fQRS group (16% vs. 2% respectively, P =.02) and pulmonary hypertension (33% vs. 14% respectively, P =.03) based on echocardiographic criteria.</p><p><strong>Conclusion: </strong>Our study demonstrates that fQRS is significantly associated with RV dilation, pulmonary hypertension, and mortality in critically unwell COVID-19 patients.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140288069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Sodium-Glucose Cotransporter 2 Inhibitors Decrease the Risk of Contrast-Associated Acute Kidney Injury in Patients with Type II Diabetes Mellitus? 钠-葡萄糖共转运体 2 抑制剂能降低 II 型糖尿病患者发生与对比度相关的急性肾损伤的风险吗?
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-03-20 DOI: 10.14744/AnatolJCardiol.2024.3980
Gizem Çabuk, Kutluhan Eren Hazır

Background: The risk of contrast-associated acute kidney injury is relatively higher in patients with diabetes mellitus compared to non-diabetics. Recent trials have revealed the renoprotective effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors. We aimed to investigate the possible preventive effect of SGLT2 inhibitors against contrast-associated acute kidney injury in the diabetic population who underwent coronary angiography with a diagnosis of stable angina or acute coronary syndrome.

Methods: This was a cross-sectional and single-center study. We enrolled 345 patients with type II diabetes mellitus who were divided into 2 groups: using an SGLT2 inhibitor (group 1; n = 133) in addition to other antidiabetic medication and not using an SGLT2 inhibitor (group 2; n = 212). Both groups were compared in terms of contrast-associated acute kidney injury incidence. We also compared groups for the duration of hospitalization.

Results: Baseline characteristics (age, sex, risk factors and medications) and laboratory findings were similar between the 2 groups. The means of administered contrast volume were also similar (160.42 (± 70.31) mL vs. 158.72 (± 81.24) mL, P = 0.83) between groups 1 and 2, respectively. We found that contrast-associated acute kidney injury incidence was significantly higher in group 2 compared to group 1 (n = 56 (26.4%) vs. n = 12 (9.0%), P < 0.001). The duration of hospitalization was significantly longer in group 2 (3.25 (± 2.03) days) than in group 1 (2.54 (± 1.39) days) (P = 0.001).

Conclusion: We found that contrast-associated acute kidney injury was significantly lower, and the duration of hospitalization was significantly shorter in diabetic patients using SGLT2 inhibitors compared to non-users.

背景:与非糖尿病患者相比,糖尿病患者发生造影剂相关急性肾损伤的风险相对较高。最近的试验显示,钠-葡萄糖共转运体 2(SGLT2)抑制剂具有肾保护作用。我们旨在研究 SGLT2 抑制剂对接受冠状动脉造影术并诊断为稳定型心绞痛或急性冠状动脉综合征的糖尿病患者造影剂相关急性肾损伤的可能预防作用:这是一项横断面单中心研究。我们招募了 345 名 II 型糖尿病患者,将其分为两组:在使用其他抗糖尿病药物的同时使用 SGLT2 抑制剂(第 1 组;n = 133)和不使用 SGLT2 抑制剂(第 2 组;n = 212)。我们对两组对比剂相关急性肾损伤的发生率进行了比较。我们还比较了两组的住院时间:结果:两组的基线特征(年龄、性别、危险因素和药物)和实验室结果相似。第 1 组和第 2 组的造影剂用量平均值也相似(分别为 160.42 (± 70.31) mL vs. 158.72 (± 81.24) mL,P = 0.83)。我们发现,对比剂相关急性肾损伤的发生率在第 2 组明显高于第 1 组(n = 56 (26.4%) vs. n = 12 (9.0%),P < 0.001)。第 2 组的住院时间(3.25 (± 2.03) 天)明显长于第 1 组(2.54 (± 1.39) 天)(P = 0.001):我们发现,与不使用 SGLT2 抑制剂的糖尿病患者相比,使用 SGLT2 抑制剂的糖尿病患者造影剂相关急性肾损伤明显降低,住院时间明显缩短。
{"title":"Do Sodium-Glucose Cotransporter 2 Inhibitors Decrease the Risk of Contrast-Associated Acute Kidney Injury in Patients with Type II Diabetes Mellitus?","authors":"Gizem Çabuk, Kutluhan Eren Hazır","doi":"10.14744/AnatolJCardiol.2024.3980","DOIUrl":"10.14744/AnatolJCardiol.2024.3980","url":null,"abstract":"<p><strong>Background: </strong>The risk of contrast-associated acute kidney injury is relatively higher in patients with diabetes mellitus compared to non-diabetics. Recent trials have revealed the renoprotective effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors. We aimed to investigate the possible preventive effect of SGLT2 inhibitors against contrast-associated acute kidney injury in the diabetic population who underwent coronary angiography with a diagnosis of stable angina or acute coronary syndrome.</p><p><strong>Methods: </strong>This was a cross-sectional and single-center study. We enrolled 345 patients with type II diabetes mellitus who were divided into 2 groups: using an SGLT2 inhibitor (group 1; n = 133) in addition to other antidiabetic medication and not using an SGLT2 inhibitor (group 2; n = 212). Both groups were compared in terms of contrast-associated acute kidney injury incidence. We also compared groups for the duration of hospitalization.</p><p><strong>Results: </strong>Baseline characteristics (age, sex, risk factors and medications) and laboratory findings were similar between the 2 groups. The means of administered contrast volume were also similar (160.42 (± 70.31) mL vs. 158.72 (± 81.24) mL, P = 0.83) between groups 1 and 2, respectively. We found that contrast-associated acute kidney injury incidence was significantly higher in group 2 compared to group 1 (n = 56 (26.4%) vs. n = 12 (9.0%), P < 0.001). The duration of hospitalization was significantly longer in group 2 (3.25 (± 2.03) days) than in group 1 (2.54 (± 1.39) days) (P = 0.001).</p><p><strong>Conclusion: </strong>We found that contrast-associated acute kidney injury was significantly lower, and the duration of hospitalization was significantly shorter in diabetic patients using SGLT2 inhibitors compared to non-users.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Publication Trends on Infective Endocarditis: Comprehensive Bibliometric Analysis and Visualization Between 1892 and 2022. 感染性心内膜炎的出版趋势:1892年至2022年间的文献计量学综合分析与可视化。
IF 1.3 4区 医学 Q3 Medicine Pub Date : 2024-03-20 DOI: 10.14744/AnatolJCardiol.2024.4277
Yağmur Ekenoğlu Merdan, Okan Aydoğan

Background: In recent years, studies reported that the incidence of infective endocarditis (IE) has increased despite the decrease in rheumatic heart diseases, great advances in medical and surgical treatment methods, and prophylactic antibiotic therapies. However, there is no bibliometric analysis based on the visual mapping method in the literature. In the study, we aimed to analyze the hot topics in IE, the distribution of publications in terms of country, institution, journal, author, and their relationships by assessing IE articles published in the 130 years between 1892 and 2022.

Methods: Publications before 2023 were analyzed using the keywords 'infective' and 'endocarditis' in the Scopus database.

Results: Approximately 25% of the publications on IE were from the USA followed by Japan, France, and the UK. A total of 116 keywords were used at least 15 times and the keywords were categorized into 9 clusters by the VOSviewer program. The keywords used more than 100 times except 'infective endocarditis' were 'echocardiography,' 'mortality,' 'surgery,' 'Staphylococcus aureus,' 'cardiac surgery,' 'epidemiology,' and 'prognosis' 247, 191, 152, 142, 130, 122, and 119 times, respectively. To the best of our knowledge, the study is the most comprehensive study globally on IE with the widest time range including the visual mapping method.

Conclusion: Since our study reveals the changes in the literature related to infective endocarditis, we think that it will be a guide in planning new research studies. We believe that periodic repetition of bibliometric analyses and keyword mapping studies will contribute to the quantitative and qualitative development of scientific productivity globally.

背景:近年来,有研究报告称,尽管风湿性心脏病有所减少,内外科治疗方法和预防性抗生素疗法也取得了巨大进步,但感染性心内膜炎(IE)的发病率仍在上升。然而,文献中还没有基于视觉映射法的文献计量分析。在本研究中,我们旨在通过评估1892年至2022年这130年间发表的IE文章,分析IE的热点话题,以及在国家、机构、期刊、作者方面的论文分布及其关系:方法:使用 Scopus 数据库中的关键词 "感染性 "和 "心内膜炎 "对 2023 年之前发表的文章进行分析:结果:约 25% 有关 IE 的论文来自美国,其次是日本、法国和英国。共有 116 个关键词至少被使用了 15 次,这些关键词被 VOSviewer 程序分为 9 组。除 "感染性心内膜炎 "外,使用次数超过 100 次的关键词有 "超声心动图"、"死亡率"、"手术"、"金黄色葡萄球菌"、"心脏手术"、"流行病学 "和 "预后",使用次数分别为 247、191、152、142、130、122 和 119 次。据我们所知,该研究是全球范围内关于 IE 的最全面的研究,时间范围最广,包括视觉映射法:由于我们的研究揭示了感染性心内膜炎相关文献的变化,因此我们认为它将为规划新的研究提供指导。我们相信,定期重复文献计量分析和关键词映射研究将有助于全球科学生产力的定量和定性发展。
{"title":"Publication Trends on Infective Endocarditis: Comprehensive Bibliometric Analysis and Visualization Between 1892 and 2022.","authors":"Yağmur Ekenoğlu Merdan, Okan Aydoğan","doi":"10.14744/AnatolJCardiol.2024.4277","DOIUrl":"10.14744/AnatolJCardiol.2024.4277","url":null,"abstract":"<p><strong>Background: </strong>In recent years, studies reported that the incidence of infective endocarditis (IE) has increased despite the decrease in rheumatic heart diseases, great advances in medical and surgical treatment methods, and prophylactic antibiotic therapies. However, there is no bibliometric analysis based on the visual mapping method in the literature. In the study, we aimed to analyze the hot topics in IE, the distribution of publications in terms of country, institution, journal, author, and their relationships by assessing IE articles published in the 130 years between 1892 and 2022.</p><p><strong>Methods: </strong>Publications before 2023 were analyzed using the keywords 'infective' and 'endocarditis' in the Scopus database.</p><p><strong>Results: </strong>Approximately 25% of the publications on IE were from the USA followed by Japan, France, and the UK. A total of 116 keywords were used at least 15 times and the keywords were categorized into 9 clusters by the VOSviewer program. The keywords used more than 100 times except 'infective endocarditis' were 'echocardiography,' 'mortality,' 'surgery,' 'Staphylococcus aureus,' 'cardiac surgery,' 'epidemiology,' and 'prognosis' 247, 191, 152, 142, 130, 122, and 119 times, respectively. To the best of our knowledge, the study is the most comprehensive study globally on IE with the widest time range including the visual mapping method.</p><p><strong>Conclusion: </strong>Since our study reveals the changes in the literature related to infective endocarditis, we think that it will be a guide in planning new research studies. We believe that periodic repetition of bibliometric analyses and keyword mapping studies will contribute to the quantitative and qualitative development of scientific productivity globally.</p>","PeriodicalId":7835,"journal":{"name":"Anatolian Journal of Cardiology","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11059227/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Anatolian Journal of Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1